These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26061123)

  • 1. Selectivity hot-spots of sirtuin catalytic cores.
    Parenti MD; Bruzzone S; Nencioni A; Del Rio A
    Mol Biosyst; 2015 Aug; 11(8):2263-72. PubMed ID: 26061123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological and catalytic functions of sirtuin 6 as targets for small-molecule modulators.
    Klein MA; Denu JM
    J Biol Chem; 2020 Aug; 295(32):11021-11041. PubMed ID: 32518153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small Molecules as SIRT Modulators.
    Bai X; Yao L; Ma X; Xu X
    Mini Rev Med Chem; 2018; 18(13):1151-1157. PubMed ID: 27334466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of Sirtuins as potential therapeutic target: Structure, function and modulators.
    Wang Y; He J; Liao M; Hu M; Li W; Ouyang H; Wang X; Ye T; Zhang Y; Ouyang L
    Eur J Med Chem; 2019 Jan; 161():48-77. PubMed ID: 30342425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New assays and approaches for discovery and design of Sirtuin modulators.
    Schutkowski M; Fischer F; Roessler C; Steegborn C
    Expert Opin Drug Discov; 2014 Feb; 9(2):183-99. PubMed ID: 24382304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for sirtuin function: what we know and what we don't.
    Sanders BD; Jackson B; Marmorstein R
    Biochim Biophys Acta; 2010 Aug; 1804(8):1604-16. PubMed ID: 19766737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human sirtuin family: evolutionary divergences and functions.
    Vassilopoulos A; Fritz KS; Petersen DR; Gius D
    Hum Genomics; 2011 Jul; 5(5):485-96. PubMed ID: 21807603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Basis of Sirtuin 6 Activation by Synthetic Small Molecules.
    You W; Rotili D; Li TM; Kambach C; Meleshin M; Schutkowski M; Chua KF; Mai A; Steegborn C
    Angew Chem Int Ed Engl; 2017 Jan; 56(4):1007-1011. PubMed ID: 27990725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and evolution of human sirtuins.
    Bordo D
    Curr Drug Targets; 2013 Jun; 14(6):662-5. PubMed ID: 23469873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirtuin-targeting drugs: Mechanisms of action and potential therapeutic applications.
    Aljada A; Dong L; Mousa SA
    Curr Opin Investig Drugs; 2010 Oct; 11(10):1158-68. PubMed ID: 20872319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sirtuins--modulation of their activity as a novel therapeutic target].
    Kucińska M; Piotrowska H; Murias M
    Pol Merkur Lekarski; 2010 Mar; 28(165):231-5. PubMed ID: 20815175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirtuin catalysis and regulation.
    Feldman JL; Dittenhafer-Reed KE; Denu JM
    J Biol Chem; 2012 Dec; 287(51):42419-27. PubMed ID: 23086947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based drug design of small molecule SIRT1 modulators to treat cancer and metabolic disorders.
    Pulla VK; Alvala M; Sriram DS; Viswanadha S; Sriram D; Yogeeswari P
    J Mol Graph Model; 2014 Jul; 52():46-56. PubMed ID: 25000096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirtuins in aging and age-related disease.
    Longo VD; Kennedy BK
    Cell; 2006 Jul; 126(2):257-68. PubMed ID: 16873059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Review of the Recent Advances Made with SIRT6 and its Implications on Aging Related Processes, Major Human Diseases, and Possible Therapeutic Targets.
    Khan RI; Nirzhor SSR; Akter R
    Biomolecules; 2018 Jun; 8(3):. PubMed ID: 29966233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential of activators and inhibitors of sirtuins.
    Balcerczyk A; Pirola L
    Biofactors; 2010; 36(5):383-93. PubMed ID: 20848588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical probing of the human sirtuin 5 active site reveals its substrate acyl specificity and peptide-based inhibitors.
    Roessler C; Nowak T; Pannek M; Gertz M; Nguyen GT; Scharfe M; Born I; Sippl W; Steegborn C; Schutkowski M
    Angew Chem Int Ed Engl; 2014 Sep; 53(40):10728-32. PubMed ID: 25111069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirtuins inhibitors: the approach to affinity and selectivity.
    Cen Y
    Biochim Biophys Acta; 2010 Aug; 1804(8):1635-44. PubMed ID: 19931429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NAD(+) -dependent histone deacetylases (sirtuins) as novel therapeutic targets.
    Schemies J; Uciechowska U; Sippl W; Jung M
    Med Res Rev; 2010 Nov; 30(6):861-89. PubMed ID: 19824050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical Probes in Sirtuin Research.
    Hu X; Zheng W
    Prog Mol Biol Transl Sci; 2018; 154():1-24. PubMed ID: 29413174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.